Dapiglutide

  • 1 lab
  • Human trial1

Outcomes

1

Body weight

downin humans1−8.3%

1 study
  1. Dapiglutide decreases body weight in humans (up to 8.3%).

    “The placebo-adjusted reductions in body weight were up to a mean of 8.3% with dapiglutide after 13 weekly doses.”

    Human trial13 weeks

    Safety, Tolerability, and Clinical Effects of Dapiglutide, a Once-Weekly GLP-1R/GLP-2R Agonist

    ADA Scientific Sessions 2025 abstract13 Jun 2025

Latest